Thursday, April 3, 2025
4/3/2025
ADAP Shortfall Relief - The Nevada Department of Health and Human Services Office of HIV (OoH) is requesting ADAP Emergency Relief funding to actively prevent the possibility of implementing an ADAP wait list for People Living with HIV (PLWH). In addition, these funds will assist in the possible funding reduction in available resources for ADAP services and address the increase of client enrollment into ADAP. From 2022 to 2024, ADAP experienced an enrollment increase of 7% (3,338 clients in 2022 vs 3,562 clients in 2024). Roughly 98% of all newly diagnosed clients in the state are eligible for ADAP, falling at or below ADAP’s federal poverty level eligibility threshold of 400%. In 2023, Nevada legislature passed Assembly Bill 434 (AB434) that OoH anticipates will greatly impact Nevada’s ADAP program from the ability to generate full 340B rebates. This impact is projected to cause a deficit of approximately three – five million dollars. The current population for Nevada based on the Census Bureau for 2024 is 3,210,930. The population is White: 58.83%, Other Race: 11.28%, Two or more races: 10.31%, Black or African American: 9.3%, Asian: 8.34%, Native American:1.24% and Native Hawaiian or Pacific Islander:0.71%. In 2023 there were 13,857 PLWH in the state of Nevada with 560 new HIV Diagnoses. Out of the 560, the top three races were 40 % Hispanic, followed by Black or African American at 26 %, and White at 25 %. Currently, 3,562 PLWH out of the 13,857 are active in the ADAP program which is 25.6 % of the current PLWH population. Nevada ADAP, also known as the Nevada Medication Assistance Program (NMAP), is a State/Territory-administered program authorized under Part B of the Ryan White HIV/AIDS Program (RWHAP) that provides FDA-approved medications to low-income individuals with HIV disease who have limited or no coverage from private insurance, Medicaid, or Medicare. Through the provision of access to HIV medications, ADAPs are a critical component of the continuum of primary care and treatment for PLWH. Other RWHAP programs work in conjunction with State/Territory ADAPs to bring people into a system of care and provide them with quality treatment and services. From 2022 to 2023 there has been a 4 % increase in PLWH in the state of Nevada, contributing to the overall steady increase of clients in the ADAP program. OoH is requesting ADAP Emergency Relief funding in the amount of $1,000,000 to prevent having to possibly implement a waitlist, address the reduction in available resources to fund ADAP, and acknowledge the increase in number of clients in the program due to new diagnosis, re-engagement in care, loss of income, and/or loss of health care coverage. In 2023, the State of Nevada passed bill AB434, which went into effect on January 1, 2024. This bill prohibits pharmacy benefit managers and health carriers from discriminating against covered entities or contract pharmacies that participate in the 340B Program, which allows certain healthcare providers to purchase drugs at discounted rates. The bill also imposes limitations on a State of Nevada Department of Health and Human Services program that provides therapeutics to persons with HIV, requiring the program to ensure that covered providers and contract pharmacies participating in the 340B Program receive the full benefit of that participation. This bill has the potential to restrict generation of 340B rebates for ADAP. This restriction will cause a projected deficit of $3,000,000 annually to the program. The ADAP ERF funds will be used to continue to fund services under the ADAP program and will hopefully supplement the potential loss of 340B rebates. The services are to include, Health Insurance Premium and Cost Sharing Assistance for Low-Income Individuals, currently fully funded by rebates, and Health Insurance to Provide Medication, funded by X07 & X08.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).